Filing Details

Accession Number:
0001209191-14-078607
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-31 17:37:50
Reporting Period:
2014-12-29
Filing Date:
2014-12-31
Accepted Time:
2014-12-31 17:37:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227886 Robert Chess C/O Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-29 29,500 $15.24 290,123 No 4 M Direct
Common Stock Disposition 2014-12-29 29,500 $15.34 260,623 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2014-12-29 29,500 $0.00 29,500 $15.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-01-02 2015-01-02 No 4 M Direct
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan for stock options expiring in the near-term.
  2. This number includes 4,914 shares held by the reporting person in the Issuer's 401(k) plan. The acquisition of these shares under that plan is exempt under Rule 16b-3(c).